Skip to Content

Notice

Sunshine Act Meeting

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

U.S. Consumer Product Safety Commission, Washington, DC 20207.

TIME AND DATE:

Friday, June 23, 2000, 10:00 a.m.

LOCATION:

Room 420, East West Towers, 4330 East West Highway, Bethesda, Maryland.

STATUS:

Open to the Public.

MATTER TO BE CONSIDERED:

Oral Drugs Switched From Prescription to Over the Counter (OTC) Status

The Commission will consider the staff's recommendation to propose that child-resistant packaging requirements for oral prescription drugs continue when such drugs are granted over-the-counter (OTC) status by the Food and Drug Administration.

For a recorded message containing the latest agenda information, call (301) 504-0709.

Start Further Info

CONTACT PERSON FOR ADDITIONAL INFORMATION:

Sadye E. Dunn, Office of the Secretary, 4330 East West Highway, Bethesda, MD 20207 (301) 504-0800.

Start Signature

Dated: June 15, 2000.

Sadye E. Dunn,

Secretary.

End Signature End Further Info End Preamble

[FR Doc. 00-15519 Filed 6-15-00; 2:27 am]

BILLING CODE 6355-01-M